Literature DB >> 25754322

Natriuretic Peptides as a Novel Target in Resistant Hypertension.

Pratik Patel1, Horng H Chen.   

Abstract

Resistant hypertension is defined as blood pressure not under goal despite being on at least three antihypertensives. Resistant hypertension is associated with significant cardiovascular morbidity and mortality. Currently, the mainstay for the treatment of resistant hypertension is lifestyle modification and antihypertensive drugs. Natriuretic peptides play an important role in regulating cardiovascular hemodynamics and sodium and fluid homeostasis including blood pressure control. They hold a promising potential for treatment of resistant hypertension.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25754322     DOI: 10.1007/s11906-014-0530-0

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  71 in total

Review 1.  Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.

Authors:  Vasilios Papademetriou; Amir Adel Rashidi; Costas Tsioufis; Michael Doumas
Journal:  Circulation       Date:  2014-04-01       Impact factor: 29.690

2.  Differential control of systolic and diastolic blood pressure : factors associated with lack of blood pressure control in the community.

Authors:  D M Lloyd-Jones; J C Evans; M G Larson; C J O'Donnell; E J Roccella; D Levy
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

3.  Prolonged decrease in blood pressure after atrial natriuretic peptide infusion in essential hypertension: a new anti-pressor mechanism?

Authors:  D R Singer; N D Markandu; M G Buckley; M A Miller; A L Sugden; G A Sagnella; G A MacGregor
Journal:  Clin Sci (Lond)       Date:  1989-09       Impact factor: 6.124

4.  Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

Authors:  W S Colucci; U Elkayam; D P Horton; W T Abraham; R C Bourge; A D Johnson; L E Wagoner; M M Givertz; C S Liang; M Neibaur; W H Haught; T H LeJemtel
Journal:  N Engl J Med       Date:  2000-07-27       Impact factor: 91.245

Review 5.  Natriuretic peptide receptor-C signaling and regulation.

Authors:  Madhu B Anand-Srivastava
Journal:  Peptides       Date:  2005-04-08       Impact factor: 3.750

6.  A gene therapy approach for long-term normalization of blood pressure in hypertensive mice by ANP-secreting human skin grafts.

Authors:  Jean-Philippe Therrien; Soo Mi Kim; Atsushi Terunuma; Yan Qin; Christine L Tock; Wolfgang Pfützner; Manabu Ohyama; Jurgen Schnermann; Jonathan C Vogel
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-11       Impact factor: 11.205

7.  Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects.

Authors:  Candace Y W Lee; Horng H Chen; Ondrej Lisy; Suzanne Swan; Courtney Cannon; Hsiao D Lieu; John C Burnett
Journal:  J Clin Pharmacol       Date:  2009-04-24       Impact factor: 3.126

8.  Systemic hemodynamics and renal function during brain natriuretic peptide infusion in patients with essential hypertension.

Authors:  C Lazzeri; F Franchi; C Porciani; C Fronzaroli; V Casini Raggi; M L De Feo; M Mannelli; R M Cersosimo; G La Villa
Journal:  Am J Hypertens       Date:  1995-08       Impact factor: 2.689

9.  Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research.

Authors:  David A Calhoun; Daniel Jones; Stephen Textor; David C Goff; Timothy P Murphy; Robert D Toto; Anthony White; William C Cushman; William White; Domenic Sica; Keith Ferdinand; Thomas D Giles; Bonita Falkner; Robert M Carey
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

10.  M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.

Authors:  Paul M McKie; Alessandro Cataliotti; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal:  J Am Heart Assoc       Date:  2014-01-02       Impact factor: 5.501

View more
  2 in total

Review 1.  Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk.

Authors:  Riccardo Sarzani; Francesco Spannella; Federico Giulietti; Paolo Balietti; Guido Cocci; Marica Bordicchia
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-04-04

2.  In-Depth Glyco-Peptidomics Approach Reveals Unexpected Diversity of Glycosylated Peptides and Atypical Post-Translational Modifications in Dendroaspis angusticeps Snake Venom.

Authors:  Michel Degueldre; Julien Echterbille; Nicolas Smargiasso; Christian Damblon; Charlotte Gouin; Gilles Mourier; Nicolas Gilles; Edwin De Pauw; Loïc Quinton
Journal:  Int J Mol Sci       Date:  2017-11-18       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.